Displaying items by tag: division of pediatric cardiology

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
The future for babies born with hypoplastic left-heart syndrome depends to a great extent upon additional cardiac issues that may not be fully known until after birth.
Ventricular assist devices offer better survival rates than ECMO therapy for children awaiting heart transplant.